In this complex landscape, the Epidermal Growth Factor Receptor (EGFR) has emerged as an established oncogene in HNSCC, being overexpressed or mutated in a percentage of cases up to about 90% (2, 7, 8). Here, EGFR is linked to head and neck squamous cell carcinoma.